Trial Profile
A Randomised Double Blind Study to Evaluate the Effect of Linagliptin on Pancreatic Beta Cell Function and Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus on Metformin Monotherapy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Voglibose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Linagliptin
- 19 May 2014 New trial record